Nanoparticle albumin-bound paclitaxel (nab-paclitaxel, nab-P) is a solvent-free colloidal suspension of paclitaxel and human serum albumin, developed to exploit the anti-tumor activity of conventional paclitaxel with a shorter infusion schedule (30 min vs. 3 h) and without the need for premedication. The gene discussed is ALB; the disease is neoplasm.